TipRanks
Shandong Xinhua Pharmaceutical Company Limited Class H (DE:XIN)
FRANKFURT:XIN
Germany Market
XIN
Shandong Xinhua Pharmaceutical Company Limited Class H
RESEARCH TOOLSreports

Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Income Statement

2 Followers

Shandong Xinhua Pharmaceutical Company Limited Class H Income Statement

Last quarter (Q2 2026), Shandong Xinhua Pharmaceutical Company Limited Class H's total revenue was ¥1.93B, a decrease of -12.80% from the same quarter last year. In Q2, Shandong Xinhua Pharmaceutical Company Limited Class H's net income was ¥64.95M. See Shandong Xinhua Pharmaceutical Company Limited Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 8.75B¥ 8.47B¥ 8.10B¥ 7.50B¥ 6.56B
Gross Profit
¥ 1.64B¥ 2.04B¥ 2.32B¥ 2.04B¥ 1.77B
Operating Expenses
¥ 1.23B¥ 1.51B¥ 1.79B¥ 1.49B¥ 1.27B
Depreciation and Amortization
¥ 587.52M¥ 540.95M¥ 516.94M¥ 484.81M¥ 434.33M
EBITDA
¥ 988.87M¥ 1.11B¥ 1.09B¥ 1.01B¥ 908.67M
Operating Income
¥ 363.98M¥ 534.37M¥ 534.58M¥ 476.71M¥ 425.59M
Other Income/Expenses
¥ -5.07M¥ -717.25K¥ -1.90M¥ -4.93M¥ -4.36M
Pretax Income
¥ 358.92M¥ 533.65M¥ 532.69M¥ 471.77M¥ 421.23M
Net Income
¥ 289.89M¥ 470.02M¥ 496.51M¥ 411.06M¥ 348.55M
Per Share Metrics
Basic EPS
¥ 0.42¥ 0.69¥ 0.72¥ 0.62¥ 0.56
Diluted EPS
¥ 0.42¥ 0.69¥ 0.72¥ 0.61¥ 0.56
Weighted Average Shares Outstanding
 689.51M 682.41M 689.60M 663.22M 622.41M
Weighted Average Shares Outstanding (Diluted)
 691.62M 682.41M 691.95M 674.09M 622.41M
Currency in CNY

Shandong Xinhua Pharmaceutical Company Limited Class H Earnings and Revenue History